Search
for
Sort by
Research 241–270 of 1000+
- Refractory/relapse thrombocytopenia in a patient with Evans' syndrome successfully treated with zanubrutinib
- Modulation of Electroosmotic Flow through Skin: Effect of Poly(Amidoamine) Dendrimers
- Stepwise acquisition of unique epigenetic signatures during differentiation of tissue Treg cells
- Mitochondrial dysfunction in metabolic syndrome and inflammatory skin disease
- Androgenetic Alopecia: Therapy Update
- Clinical review 74: Dermatological manifestations of endocrine disorders.
- Alopecia Areata
- The successful treatment of nephrogenic fibrosing dermopathy (NFD) with mycophenolate mofetil (MMF)
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- K <sub>ATP</sub> Channels and Cardiovascular Disease
- The role of lymphocytes in the development and treatment of alopecia areata
- Skin Diseases (Noncancerous)
- Menopause - Andropause - Anti-Aging 2008, 11.-13. Dezember 2008, Wien - Abstracts
- An Update on Drug-Induced Pigmentation
- Ppp2r2a Knockout Mice Reveal That Protein Phosphatase 2A Regulatory Subunit, PP2A-B55α, Is an Essential Regulator of Neuronal and Epidermal Embryonic Development
- Non‐infective mucocutaneous presentations of human immunodeficiency virus infection
- Immunoregulatory Effects of Myeloid-Derived Suppressor Cell Exosomes in Mouse Model of Autoimmune Alopecia Areata
- An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
- Answer
- Cancer-Related Alopecia: From Etiologies to Global Management
- Phototherapy with Topical Minoxidil in Vitiligo: A Randomized Control Trial
- Biomaterial-based mechanical regulation facilitates scarless wound healing with functional skin appendage regeneration
- Genetic Basis of Alopecia Areata
- Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 Diabetes
- Proteasome Inhibitors: An Expanding Army Attacking a Unique Target
- Calreticulin: non‐endoplasmic reticulum functions in physiology and disease
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak
- Production of a 135-residue long N-truncated human keratinocyte growth factor 1 in Escherichia coli
- In vivo expression of VCAM1 precedes nephron loss following kidney tubular necrosis